In Vitro Fertilization Market Size, Share, Growth Analysis, By Product Type(Fresh Donor, Fresh Non-Donor, Frozen Donor, and Frozen Non-Donor), By End-use(Fertility Clinics, Surgical Centers, Hospitals, Research Institutes), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2163 | Region: Global | Published Date: March, 2024
Pages: 219 |Tables: 65 |Figures: 75

In Vitro Fertilization Market Insights

Global In Vitro Fertilization Market size was valued at USD 23.75 Billion in 2022 and is poised to grow from USD 25.10 Billion in 2023 to USD 39.11 Billion by 2031, at a CAGR of 5.7% during the forecast period (2024-2031).

The global In vitro fertilization market refers to the market for assisted reproductive technology (ART) procedures that involve the fertilization of an egg with sperm outside the human body. IVF has become a widely accepted method for treating infertility and enabling couples to conceive. It involves various procedures such as ovarian stimulation, egg retrieval, fertilization, and embryo transfer. The primary purpose of the IVF market is to offer a solution to couples facing fertility issues and help them achieve successful pregnancies. IVF is used when natural conception is not possible or has a low probability of success. The market provides individuals and couples with options to overcome infertility challenges and realize their desire to have children. The global infertility rates have been rising due to factors such as lifestyle changes, delayed pregnancies, hormonal disorders, and medical conditions. Technological advancements in IVF procedures, such as improvements in laboratory techniques, cryopreservation methods, genetic testing, and embryo selection, have significantly improved success rates. These advancements attract couples seeking effective and reliable fertility treatments. IVF treatment often involves a challenging emotional and physical journey for couples. The intensive treatment process, uncertainties around success rates, and emotional stress can act as barriers for some individuals or couples in pursuing IVF. The demand for IVF procedures is rising in developing regions, where access to fertility treatments and awareness about available options are improving. This presents opportunities for market expansion and the establishment of IVF clinics in these regions. Opportunities lie in the growing demand from developing regions and technological innovations that can improve success rates and patient experience. The IVF market continues to evolve as new techniques and approaches emerge, providing hope and options for couples seeking to start or expand their families.

Market Snapshot - 2024-2031

Global Market Size

USD 23.75 Billion

Largest Segment

Frozen Non-Donor

Fastest Growth

Fresh Non-Donor

Growth Rate

5.7% CAGR

Global In Vitro Fertilization Market 2022-2030 ($ Bn)
Country Share for Asia Pacific Region- 2022 (%)

To get more reports on the above market click here to Buy The Report

In Vitro Fertilization Market Segmental Analysis

The global in vitro fertilization market is segmented on the basis of product, end-use, and region. Based on product, the market is grouped into fresh donor, fresh non-donor, frozen donor, and frozen non-donor. In terms of end-use, the market is segmented into fertility clinics, surgical centers, hospitals, and research institutes. Regionwise, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global In Vitro Fertilization Market Analysis by Product

In 2022, the fresh non-donor segment emerged as the dominant segment in the global IVF market, accounting for 49% of the revenue share. This segment's dominance can be attributed to several factors, including its high success rate, higher birth rates compared to frozen embryos, ease of implantation, and better results from fresh embryo transfers. The increasing adoption of fresh non-donor cycles, coupled with the growing prevalence of infertility worldwide, acts as a major driver for this segment. It is expected that the popularity of the fresh non-donor cycle will continue to sustain its dominance throughout the forecast period.

The frozen non-donor segment is projected to experience the fastest growth during the forecast period. This growth can be primarily attributed to the higher pregnancy rates associated with frozen transfers and the comparatively lower cost. The frozen non-donor cycle offers greater convenience for both patients and endocrinologists. Additionally, this cycle causes less stress on the physical and mental health of women, further fueling the growth of this segment in the coming years.

Global In Vitro Fertilization Market Analysis by End-use

In 2022, the fertility clinics segment accounted for 80% of the revenue share in the global IVF market. Fertility clinics are the preferred choice for couples seeking diagnosis and treatment for fertility-related issues. These specialized clinics offer dedicated care services to individuals and couples, addressing their pregnancy and fertility problems. The growth of the fertility clinics segment can be attributed to factors such as the increasing number of fertility clinics, growing awareness about their services, and declining fertility rates worldwide.

hospitals are expected to present significant opportunities in the IVF market. The widespread presence of hospitals, improving healthcare infrastructure in developing countries, round-the-clock availability of healthcare professionals, and the availability of advanced surgical tools and equipment contribute to the demand for hospital services in the field of IVF treatment.

Global In Vitro Fertilization Market Size By Product, 2022(%)

To get detailed analysis on other segments, Request For Free Sample Report

In Vitro Fertilization Market Regional Insights

In 2022, Asia Pacific region is expected to witness a remarkable compound annual growth rate (CAGR) during the forecast period in the in-vitro fertilization (IVF) market. This growth can be attributed to several factors, including the large population base, rapidly declining fertility rates, increasing government initiatives focused on women, a growing preference for careers over starting a family among women, and increased awareness regarding fertility clinics and procedures. The region benefits from growing awareness of IVF, rising healthcare expenditure, and increased adoption of advanced reproductive technology. Additionally, the rise of medical tourism in the region is expected to impact the growth of the IVF market. countries like Japan and South Korea are facing declining population rates due to the increasing median age of first-time mothers. Women in these countries prioritize their careers and tend to delay starting a family during their 20s. This trend results in delayed marriages and pregnancies. Women over the age of 35 have a higher risk of miscarriage and stillbirth, which can lower the success rate of fertility treatments.

In North America, there has been a significant decline in fertility rates among both men and women. Factors such as the increasing prevalence of polycystic ovary syndrome, the rising number of fertility clinics, improved government reimbursement policies for fertility issues, and increased healthcare expenditure contribute to the growth of the IVF market in North America. Delayed marriages and pregnancies, rising obesity rates, and increased alcohol consumption are primary factors behind the surging infertility rates, driving the IVF market in North America.

Global In Vitro Fertilization Market Size By Geography, 2022-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

In Vitro Fertilization Market Dynamics

Global In Vitro Fertilization Market Drivers

Advancements in Reproductive Technologies

  • In 2021, there were significant advancements in reproductive technologies used in IVF procedures. For instance, the introduction of time-lapse imaging systems allowed continuous monitoring of embryo development, leading to improved selection and higher success rates. These advancements attracted more individuals and couples to undergo IVF treatments.

Increasing Awareness and Acceptance

  • Growing awareness about infertility issues and the availability of IVF treatments contributed to increased acceptance and demand for IVF procedures. Celebrities and public figures openly sharing their experiences with IVF helped reduce the stigma associated with infertility and encouraged more people to consider IVF as a viable option.

Global In Vitro Fertilization Market Restraints

High Cost of Treatment

  • The cost of IVF treatments remained a significant restraint in 2021. The expenses associated with medications, laboratory procedures, and multiple treatment cycles can be substantial, making IVF inaccessible to many individuals and couples, particularly those without adequate financial resources or insurance coverage.

Ethical and Legal Concerns

  • IVF procedures involve various ethical and legal considerations, such as the use of donor gametes, embryo storage, and embryo selection. These concerns can create regulatory challenges and variations in IVF practices across different countries and regions, impacting the market's growth and standardization.

Request Free Customization of this report to help us to meet your business objectives.

In Vitro Fertilization Market Competitive Landscape

The global In vitro fertilization market is characterized by the presence of several key players, including fertility clinics, medical device manufacturers, pharmaceutical companies, and genetic testing laboratories. These companies compete based on factors such as product offerings, technology advancements, success rates, pricing, and geographical presence. Here is an elaboration on the competitive landscape of the IVF market. Companies in the IVF market also engage in strategic initiatives such as mergers and acquisitions, partnerships, and collaborations to expand their product portfolios, enhance their geographic presence, and strengthen their research and development capabilities. They also invest in technological advancements, such as time-lapse imaging systems, embryo selection algorithms, and cryopreservation techniques, to improve success rates and patient experience.

Top Player’s Company Profiles in Global In Vitro Fertilization Market

  • CooperSurgical, Inc. (US)
  • Vitrolife AB (Sweden)
  • Cook Medical (US)
  • Irvine Scientific (US)
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Esco Micro Pte Ltd (Singapore)
  • Genea Limited (Australia)
  • Ferring Pharmaceuticals (Switzerland)
  • Hamilton Thorne, Inc. (Canada)
  • Nidacon International AB (Sweden)
  • Rocket Medical plc (UK)
  • EMD Serono (US)
  • OvaScience (US)
  • Kitazato Corporation (Japan)
  • IVFtech Aps (Denmark)
  • Zeiss Group (Germany)
  • Igenomix (Spain)
  • Labotect GmbH (Germany)
  • Esco Medical (Singapore)

Global In Vitro Fertilization Market Recent Developments

  • June of 2023 The debut of MilliporeSigma's new CellToxTM Assay Platform was announced. The platform consists of a collection of in vitro tests intended to evaluate the safety of substances and medications.

  • WuXi AppTec announced in May 2023 that its in vitro toxicological capabilities have expanded. New assays will be included as part of the expansion, and a new service for creating personalized in vitro assays will be introduced.

  • Thermo Fisher Scientific Inc. said in April 2023 that it had acquired CooperSurgical, an IVF supplier of goods and services. Thermo Fisher will be able to increase its market share in the IVF sector thanks to the acquisition.

  • Vitrolife declared in March 2023 that the FDA has approved its Cryotop vitrification device. A novel method for vitrifying embryos—a quick freezing procedure used to maintain their viability—is the Cryotop system.

In Vitro Fertilization Key Market Trends

  • Rising Demand for Genetic Testing: In 2022, there was a growing trend towards the use of genetic testing techniques, such as preimplantation genetic testing (PGT), in IVF procedures. PGT allows the screening of embryos for genetic abnormalities before implantation, increasing the chances of successful pregnancies and reducing the risk of genetic disorders in offspring.
  • Increasing Focus on Personalized Medicine: Personalized medicine gained prominence in the IVF market in 2021. The approach involves tailoring IVF treatment protocols based on individual patient characteristics, such as age, ovarian reserve, and specific fertility challenges. Personalized medicine aims to optimize treatment outcomes and improve the efficiency of IVF procedures.

In Vitro Fertilization Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global in vitro fertilization market analysis, IVF procedures have become increasingly popular as a solution for individuals and couples facing fertility challenges, thereby creating growth opportunities for this market. The IVF market has experienced substantial growth in recent years and is projected to continue expanding. Factors such as increasing infertility rates, advancements in reproductive technologies, and growing awareness and acceptance of IVF treatments contribute to market growth. The IVF market exhibits regional variations in terms of market size, growth opportunities, and adoption rates.

The market has shown resilience and is expected to recover as healthcare systems stabilize. The global IVF market presents significant growth opportunities driven by increasing infertility rates, technological advancements, and expanding awareness. However, challenges such as high costs, ethical considerations, and regulatory complexities need to be addressed for a sustainable market.

Report Metric Details
Market size value in 2022 USD 23.75 Billion
Market size value in 2031 USD 39.11 Billion
Growth Rate 5.7%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product Type
    • Fresh Donor, Fresh Non-Donor, Frozen Donor, and Frozen Non-Donor
  • End-use
    • Fertility Clinics, Surgical Centers, Hospitals, Research Institutes
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • CooperSurgical, Inc. (US)
  • Vitrolife AB (Sweden)
  • Cook Medical (US)
  • Irvine Scientific (US)
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Esco Micro Pte Ltd (Singapore)
  • Genea Limited (Australia)
  • Ferring Pharmaceuticals (Switzerland)
  • Hamilton Thorne, Inc. (Canada)
  • Nidacon International AB (Sweden)
  • Rocket Medical plc (UK)
  • EMD Serono (US)
  • OvaScience (US)
  • Kitazato Corporation (Japan)
  • IVFtech Aps (Denmark)
  • Zeiss Group (Germany)
  • Igenomix (Spain)
  • Labotect GmbH (Germany)
  • Esco Medical (Singapore)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on In Vitro Fertilization Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on In Vitro Fertilization Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the In Vitro Fertilization Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the In Vitro Fertilization Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the In Vitro Fertilization Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the In Vitro Fertilization Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global In Vitro Fertilization Market size was valued at USD 23.75 Billion in 2022 and is poised to grow from USD 25.10 Billion in 2023 to USD 39.11 Billion by 2031, at a CAGR of 5.7% during the forecast period (2024-2031).

The global In vitro fertilization market is characterized by the presence of several key players, including fertility clinics, medical device manufacturers, pharmaceutical companies, and genetic testing laboratories. These companies compete based on factors such as product offerings, technology advancements, success rates, pricing, and geographical presence. Here is an elaboration on the competitive landscape of the IVF market. Companies in the IVF market also engage in strategic initiatives such as mergers and acquisitions, partnerships, and collaborations to expand their product portfolios, enhance their geographic presence, and strengthen their research and development capabilities. They also invest in technological advancements, such as time-lapse imaging systems, embryo selection algorithms, and cryopreservation techniques, to improve success rates and patient experience. 'CooperSurgical, Inc. (US)', 'Vitrolife AB (Sweden)', 'Cook Medical (US)', 'Irvine Scientific (US)', 'Merck KGaA (Germany)', 'Thermo Fisher Scientific, Inc. (US)', 'Esco Micro Pte Ltd (Singapore)', 'Genea Limited (Australia)', 'Ferring Pharmaceuticals (Switzerland)', 'Hamilton Thorne, Inc. (Canada)', 'Nidacon International AB (Sweden)', 'Rocket Medical plc (UK)', 'EMD Serono (US)', 'OvaScience (US)', 'Kitazato Corporation (Japan)', 'IVFtech Aps (Denmark)', 'Zeiss Group (Germany)', 'Igenomix (Spain)', 'Labotect GmbH (Germany)', 'Esco Medical (Singapore)'

In 2021, there were significant advancements in reproductive technologies used in IVF procedures. For instance, the introduction of time-lapse imaging systems allowed continuous monitoring of embryo development, leading to improved selection and higher success rates. These advancements attracted more individuals and couples to undergo IVF treatments.

Rising Demand for Genetic Testing: In 2022, there was a growing trend towards the use of genetic testing techniques, such as preimplantation genetic testing (PGT), in IVF procedures. PGT allows the screening of embryos for genetic abnormalities before implantation, increasing the chances of successful pregnancies and reducing the risk of genetic disorders in offspring.

In 2022, Asia Pacific region is expected to witness a remarkable compound annual growth rate (CAGR) during the forecast period in the in-vitro fertilization (IVF) market. This growth can be attributed to several factors, including the large population base, rapidly declining fertility rates, increasing government initiatives focused on women, a growing preference for careers over starting a family among women, and increased awareness regarding fertility clinics and procedures. The region benefits from growing awareness of IVF, rising healthcare expenditure, and increased adoption of advanced reproductive technology. Additionally, the rise of medical tourism in the region is expected to impact the growth of the IVF market. countries like Japan and South Korea are facing declining population rates due to the increasing median age of first-time mothers. Women in these countries prioritize their careers and tend to delay starting a family during their 20s. This trend results in delayed marriages and pregnancies. Women over the age of 35 have a higher risk of miscarriage and stillbirth, which can lower the success rate of fertility treatments.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35H2163

$5,300
BUY NOW GET FREE SAMPLE